CN102166279A - Chinese medicinal composition for improving ovarian response and application thereof - Google Patents
Chinese medicinal composition for improving ovarian response and application thereof Download PDFInfo
- Publication number
- CN102166279A CN102166279A CN 201110098135 CN201110098135A CN102166279A CN 102166279 A CN102166279 A CN 102166279A CN 201110098135 CN201110098135 CN 201110098135 CN 201110098135 A CN201110098135 A CN 201110098135A CN 102166279 A CN102166279 A CN 102166279A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- liquid
- angelicae sinensis
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 230000002611 ovarian Effects 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims description 67
- 238000002360 preparation method Methods 0.000 claims description 38
- 239000008187 granular material Substances 0.000 claims description 35
- 239000000843 powder Substances 0.000 claims description 32
- 210000000582 semen Anatomy 0.000 claims description 22
- 210000001672 ovary Anatomy 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000131360 Morinda citrifolia Species 0.000 abstract 1
- 235000008898 Morinda citrifolia Nutrition 0.000 abstract 1
- 235000008248 Morinda citrifolia var citrifolia Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 235000017524 noni Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 80
- 239000007788 liquid Substances 0.000 description 75
- 239000000284 extract Substances 0.000 description 35
- 239000008194 pharmaceutical composition Substances 0.000 description 20
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 238000000605 extraction Methods 0.000 description 15
- 239000012535 impurity Substances 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- 239000007921 spray Substances 0.000 description 15
- 239000006071 cream Substances 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 6
- 239000004375 Dextrin Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000686 essence Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 208000000509 infertility Diseases 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 208000021267 infertility disease Diseases 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010027295 Menometrorrhagia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a Chinese medicinal composition for improving ovarian response, which comprises the following raw materials in part by weight: 100 to 300 parts of Chinese angelica, 200 to 500 parts of prepared rehmannia root, 150 to 450 parts of south dodder seed, 200 to 500 parts of glossy privet fruit, 150 to 450 parts of himalayan teasel root, 100 to 300 parts of root of red-rooted salvia and 100 to 300 parts of medicinal indianmulberry root. The Chinese medicinal composition is supported by the substantial classical theory of gynecology in Chinese medical science, has a reasonable component proportion, a few herbal medicines in a prescription, low cost, and a definite clinical curative effect, does not have toxic or side effect, is safe in administration, and can be used for improving the ovarian response in in-vitro fertilization-embryo transplantation, and quality is easy to control.
Description
Technical field
The invention belongs to Chinese medicine composition, relate to a kind of Chinese medicine composition that is used for improving the vitro fertilization-embryo implanting ovary response, can be used for improving application in the medicine of vitro fertilization-embryo implanting ovary response in preparation.
Background technology
The vitro fertilization-embryo implanting technology is the important means that solves the sterility and infertility problem.Ovary response is the key factor that can the vitro fertilization-embryo implanting technology successfully become pregnant.Chinese medicine composition has clear superiority aspect the ovary response in improving vitro fertilization-embryo implanting.
Chinese medicine thinks that kidney qi is contained, the menses maturation, and make the conception vessel circulation, and chong channel is arrogant, acts on the uterus, dashes and appoint, and makes it QI and blood and is in harmonious proportion, and the men and women joins in good time, and two essences are fought mutually, and then tire is pregnant is to become.If asthenia of renal qi undermines menses, Chong and Ren channel disorder is qi-blood disharmony, all can influence the pregnant formation of tire.Kidney storing essence, essence can be changed into QI, the growth of human body, growth and reproduction are being dominated in the prosperity and decline of essence in kidney, and dominant force kidney-menses-dash and appoint-coordination of uterus reproduction s function.If congenital deficiency of kidney-QI, or intemperate sexual intercourse, prolonged illness is impairment of the kidney, and kidney qi secretly consumes, and then dashes and appoints void to decline, and vessels of the uterus loses supports, and can not become pregnant by consolidating semen; If insufficiency of kidney-YANG, decline of the fire from the gate of life is dashed to appoint and is lost in warm, can not become pregnant by consolidating semen; If deficiency of kidney yin, the essence and blood loss, born of the same parents lose moist, even hyperactivity of fire caused by deficiency of YIN, sea of blood intrinsic heat, Chong and Ren channel disorder all can not become pregnant by consolidating semen, sends out to be infertility." Yizong Jinjian gynecological heart method gist ": the event of infertilitas feminis, dash also by hindering it.Through saying: woman two or seven and menarche, conception vessel is logical, and taichong channel is contained, and regular menstrual cycle is so can there be son.Dash the arteries and veins of appointing if the heresy of three the moon is hindered it, diease occurrences such as menoxenia, leucorrhea with red and white discharge, menometrorrhagia, metrorrhagia are then arranged here.Or because of stagnated blood amasss in born of the same parents, it is pregnant that fresh blood can not become, or because of the cold born of the same parents' heat of born of the same parents, can not become pregnant by consolidating semen, or contain abundant expectoration because of body, and adipose membrane is jammed among the born of the same parents and infertile.All ought sift its because of, by card medical treatment, self energy has son also." on the Shen Shi woman section summary volume ": this asks the full QI and blood abundance that relies of son, and it is loss of fecundity that void declines.So Xue Li vegetarian cloud: examine men and women's chi pulse to being in ... right this special its body void of speech and conception failture person are also.The conception failture person must have his disease if body is not empty.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition that improves ovary response, it mainly is a kind of Chinese medicine composition that is used for improving the vitro fertilization-embryo implanting ovary response, the preparation of per 1000 dosage units of this Chinese medicine composition is formed (weight proportion) by following proportion raw material: Radix Angelicae Sinensis 100-300 part, Radix Rehmanniae Preparata 200-500 part, Semen Cuscutae 150-450 part, Fructus Ligustri Lucidi 200-500 part, Radix Dipsaci 150-450 part, Radix Salviae Miltiorrhizae 100-300 part, Radix Morindae Officinalis 100-300 part.The weight of above component is calculated with crude drug.Per 1 part can be 1g, also can be kilogram or ton, if be unit with gram, this prescription composition can be made into 1000 doses of pharmaceutical preparatioies.Described 1000 doses of fingers, the final drug preparation of making, as make granule 1000g etc., also can make big packing as granule, as the 100-500 bag, specifically can be 100 bags, 125 bags, 200 bags, 250 bags, 500 bags etc., every bag can be used as taking dose one time.
More than form, can be made into the preparation of 50-1000 taking dose,, make 125 bags, take the 1-2 bag at every turn, can take 62.5-125 time altogether as granule.
More than form to be by weight as proportioning, when producing, can or reduce according to the corresponding proportion increase, as large-scale production can be unit with the kilogram, or be unit with the ton, small-scale production can milligram be a unit also, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The Chinese medicine composition of said ratio adds suitable excipient as required and makes suitable medicinal any dosage form, and said preparation can be multiple suitable dosage forms such as capsule, granule, tablet, powder.
Another object of the present invention provides described Chinese medicine composition and is used for improving application in the medicine of vitro fertilization-embryo implanting ovary response in preparation.
Usefulness of the present invention is: (1) pharmaceutical composition of the present invention has solid TCM Gynecology classical theory support, reasonable mixture ratio of components; (2) pharmaceutical composition clinical efficacy of the present invention is definite, has no side effect, and takes safety, can use in preparation is used for improving the Chinese medicine composition of vitro fertilization-embryo implanting ovary response; (3) pharmaceutical composition flavour of a drug of the present invention are few, are easy to quality control, and are simultaneously with low cost.
The specific embodiment
The present invention is further described by specific embodiment.
Embodiment 1 granule preparation of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 100g, Radix Rehmanniae Preparata 200g, Semen Cuscutae 150g, Fructus Ligustri Lucidi 200g, Radix Dipsaci 150g, Radix Salviae Miltiorrhizae 100g, Radix Morindae Officinalis 100g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) add 0.75g dextrin and the mixing of 1g Icing Sugar amount by the 1g dried cream powder, granulate with 85% ethanol moistening, wet grain drying (50 ℃ of pathogenic wind-warm), granulate is made 1000 doses of granules, promptly.
Embodiment 2 preparation tablets of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 100g, Radix Rehmanniae Preparata 200g, Semen Cuscutae 150g, Fructus Ligustri Lucidi 200g, Radix Dipsaci 150g, Radix Salviae Miltiorrhizae 100g, Radix Morindae Officinalis 100g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) by the 1g dried cream powder add lactose 495g, protein sugar 45g, 90-95% ethanol 50ml makes granule, dried granule adds tabletting behind the magnesium stearate 30g mixing, makes 1000 in tablet, promptly.
Embodiment 3 capsule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 100g, Radix Rehmanniae Preparata 200g, Semen Cuscutae 150g, Fructus Ligustri Lucidi 200g, Radix Dipsaci 150g, Radix Salviae Miltiorrhizae 100g, Radix Morindae Officinalis 100g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) above dry extract is broken into fine powder, incapsulates, make 1000 of capsules, promptly.
Embodiment 4 granule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 150g, Radix Rehmanniae Preparata 275g, Semen Cuscutae 225g, Fructus Ligustri Lucidi 275g, Radix Dipsaci 225g, Radix Salviae Miltiorrhizae 150g, Radix Morindae Officinalis 150g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) add 0.75g dextrin and the mixing of 1g Icing Sugar amount by the 1g dried cream powder, granulate with 85% ethanol moistening, wet grain drying (50 ℃ of pathogenic wind-warm), granulate is made 1000 doses of granules, promptly.
Embodiment 5 preparation tablets of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 150g, Radix Rehmanniae Preparata 275g, Semen Cuscutae 225g, Fructus Ligustri Lucidi 275g, Radix Dipsaci 225g, Radix Salviae Miltiorrhizae 150g, Radix Morindae Officinalis 150g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) by the 1g dried cream powder add lactose 495g, protein sugar 45g, 90-95% ethanol 50ml makes granule, dried granule adds tabletting behind the magnesium stearate 30g mixing, makes 1000 in tablet, promptly.
Embodiment 6 capsule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 150g, Radix Rehmanniae Preparata 275g, Semen Cuscutae 225g, Fructus Ligustri Lucidi 275g, Radix Dipsaci 225g, Radix Salviae Miltiorrhizae 150g, Radix Morindae Officinalis 150g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) above dry extract is broken into fine powder, incapsulates, make 1000 of capsules, promptly.
Embodiment 7 granule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 200g, Radix Rehmanniae Preparata 350g, Semen Cuscutae 300g, Fructus Ligustri Lucidi 350g, Radix Dipsaci 300g, Radix Salviae Miltiorrhizae 200g, Radix Morindae Officinalis 200g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) add 0.75g dextrin and the mixing of 1g Icing Sugar amount by the 1g dried cream powder, granulate with 85% ethanol moistening, wet grain drying (50 ℃ of pathogenic wind-warm), granulate is made 1000 doses of granules, promptly.
Embodiment 8 preparation tablets of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 200g, Radix Rehmanniae Preparata 350g, Semen Cuscutae 300g, Fructus Ligustri Lucidi 350g, Radix Dipsaci 300g, Radix Salviae Miltiorrhizae 200g, Radix Morindae Officinalis 200g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) by the 1g dried cream powder add lactose 495g, protein sugar 45g, 90-95% ethanol 50ml makes granule, dried granule adds tabletting behind the magnesium stearate 30g mixing, makes 1000 in tablet, promptly.
Embodiment 9 capsule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 200g, Radix Rehmanniae Preparata 350g, Semen Cuscutae 300g, Fructus Ligustri Lucidi 350g, Radix Dipsaci 300g, Radix Salviae Miltiorrhizae 200g, Radix Morindae Officinalis 200g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) above dry extract is broken into fine powder, incapsulates, make 1000 of capsules, promptly.
Embodiment 10 granule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 250g, Radix Rehmanniae Preparata 425g, Semen Cuscutae 375g, Fructus Ligustri Lucidi 425g, Radix Dipsaci 375g, Radix Salviae Miltiorrhizae 250g, Radix Morindae Officinalis 250g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) add 0.75g dextrin and the mixing of 1g Icing Sugar amount by the 1g dried cream powder, granulate with 85% ethanol moistening, wet grain drying (50 ℃ of pathogenic wind-warm), granulate is made 1000 doses of granules, promptly.
Embodiment 11 preparation tablets of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 250g, Radix Rehmanniae Preparata 425g, Semen Cuscutae 375g, Fructus Ligustri Lucidi 425g, Radix Dipsaci 375g, Radix Salviae Miltiorrhizae 250g, Radix Morindae Officinalis 250g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) by the 1g dried cream powder add lactose 495g, protein sugar 45g, 90-95% ethanol 50ml makes granule, dried granule adds tabletting behind the magnesium stearate 30g mixing, makes 1000 in tablet, promptly.
Embodiment 12 capsule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 250g, Radix Rehmanniae Preparata 425g, Semen Cuscutae 375g, Fructus Ligustri Lucidi 425g, Radix Dipsaci 375g, Radix Salviae Miltiorrhizae 250g, Radix Morindae Officinalis 250g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) above dry extract is broken into fine powder, incapsulates, make 1000 of capsules, promptly.
Embodiment 13 granule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 300g, Radix Rehmanniae Preparata 500g, Semen Cuscutae 450g, Fructus Ligustri Lucidi 500g, Radix Dipsaci 450g, Radix Salviae Miltiorrhizae 300g, Radix Morindae Officinalis 300g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) add 0.75g dextrin and the mixing of 1g Icing Sugar amount by the 1g dried cream powder, granulate with 85% ethanol moistening, wet grain drying (50 ℃ of pathogenic wind-warm), granulate is made 1000 doses of granules, promptly.
Embodiment 14 preparation tablets of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 300g, Radix Rehmanniae Preparata 500g, Semen Cuscutae 450g, Fructus Ligustri Lucidi 500g, Radix Dipsaci 450g, Radix Salviae Miltiorrhizae 300g, Radix Morindae Officinalis 300g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) by the 1g dried cream powder add lactose 495g, protein sugar 45g, 90-95% ethanol 50ml makes granule, dried granule adds tabletting behind the magnesium stearate 30g mixing, makes 1000 in tablet, promptly.
Embodiment 15 capsule preparations of the present invention
Pharmaceutical composition is formed: Radix Angelicae Sinensis 300g, Radix Rehmanniae Preparata 500g, Semen Cuscutae 450g, Fructus Ligustri Lucidi 500g, Radix Dipsaci 450g, Radix Salviae Miltiorrhizae 300g, Radix Morindae Officinalis 300g.
Preparation method:
(1) above seven flavor medicine, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Morindae Officinalis adds 10 times of amount 70% alcohol reflux 1.0 hours, extracts secondary altogether, and merge extractive liquid, reclaims ethanol.60 ℃ are evaporated to relative density of medicine liquid 1.05(30 ℃ survey), with 14000 rev/mins of centrifugal remove impurity of tube centrifuge.Centrifugal liquid and alcohol extraction medicinal liquid merge, and 60 ℃ are evaporated to relative density of medicine liquid 1.15(60 ℃ survey).Concentrated solution prepares extract powder with spray dryer (control hydrojet speed is 2000ml/min, 140 ℃ of intake air temperatures, 85 ℃ of air outlet temperature).
(2) above dry extract is broken into fine powder, incapsulates, make 1000 of capsules, promptly.
Embodiment 16
1. case is collected and grouping:
Choose the patient of 52 examples because of tubal infertility row vitro fertilization-embryo implanting.Be divided into treatment group 26 example and matched group 26 examples at random.Each group there are no significant at age, the infertile time limit, Body Mass Index, menstruation the 3rd day aspect such as FSH, LH, E2 difference has comparability.
2. Therapeutic Method
All patients all adopt conventional rectangular case (GnRHa+rFSH) induced ovulation scheme.Treatment group patient IVF falling tone cycle menstruation rose and takes this pharmaceutical composition (form: Radix Angelicae Sinensis 20g, Radix Rehmanniae Preparata 35g, Semen Cuscutae 30g, Fructus Ligustri Lucidi 35g, Radix Dipsaci 30g, Radix Salviae Miltiorrhizae 20g, Radix Morindae Officinalis 20g) simultaneously on the 3rd day, was decocted in water for oral dose 1 dose of every day, every day 2 times, serve on 28 days.
3. observation of curative effect:
Relatively two groups of patients' promoting ovulation drug consumption, HCG day blood E2 value and FSH value, obtain ovum rate, rate of fertilization, embryo quality rate, implantation rate, pregnancy rate, cycle cancellation rate.
4. result: this pharmaceutical composition can significantly improve vitro fertilization-embryo implanting person's ovary response,
| Group | Matched group (n=26) | Treatment group (n=26) |
| Cycle cancellation rate | 2（7.7%） | 1（3.8%） |
| The ovarian stimulation natural law | 10±2 | 9±2 |
| Gn dosage (IU) | 2587±933 | 2172±522 |
| HCG day blood E2 (pmol/L) | 13257±9212 | 12892±8085 |
| Obtain the ovum number | 12±8 | 15±6 |
| Rate of fertilization (%) | 61.1±23.0 | 66.1±20.6 |
| Spilting of an egg embryo number | 8±5 | 8±4 |
| The embryo quality number | 5±4 | 6±3 |
| Pregnancy rate (%) | 33.9 | 36. |
Treatment group and matched group compare, and there is significant difference * p＜0.05.
Claims (3)
1. Chinese medicine composition that improves ovary response, it is characterized in that, this Chinese medicine composition is made by following materials of weight proportions: Radix Angelicae Sinensis 100-300 part, Radix Rehmanniae Preparata 200-500 part, Semen Cuscutae 150-450 part, Fructus Ligustri Lucidi 200-500 part, Radix Dipsaci 150-450 part, Radix Salviae Miltiorrhizae 100-300 part, Radix Morindae Officinalis 100-300 part.
2. a kind of Chinese medicine composition that improves ovary response according to claim 1 is used for improving application in the medicine of vitro fertilization-embryo implanting ovary response in preparation.
3. application according to claim 2 is characterized in that, the dosage form of described medicine is capsule, granule, tablet or powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100981352A CN102166279B (en) | 2011-04-19 | 2011-04-19 | Chinese medicinal composition for improving ovarian response and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100981352A CN102166279B (en) | 2011-04-19 | 2011-04-19 | Chinese medicinal composition for improving ovarian response and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102166279A true CN102166279A (en) | 2011-08-31 |
| CN102166279B CN102166279B (en) | 2012-07-04 |
Family
ID=44487722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100981352A Expired - Fee Related CN102166279B (en) | 2011-04-19 | 2011-04-19 | Chinese medicinal composition for improving ovarian response and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102166279B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257879A (en) * | 2014-09-11 | 2015-01-07 | 成都中医药大学 | Novel use of Wuzi Yanzong prescription |
| CN109528980A (en) * | 2019-01-18 | 2019-03-29 | 北京厚成医药科技有限公司 | A kind of Chinese medicine composition and its pharmacy application for treating Ovary reserve decline disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279090A (en) * | 1999-06-25 | 2001-01-10 | 刘永香 | Powdered medicine for conditioning viscera and whole body |
| CN1478509A (en) * | 2003-03-28 | 2004-03-03 | 刘晓雷 | Health-care liquid |
-
2011
- 2011-04-19 CN CN2011100981352A patent/CN102166279B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279090A (en) * | 1999-06-25 | 2001-01-10 | 刘永香 | Powdered medicine for conditioning viscera and whole body |
| CN1478509A (en) * | 2003-03-28 | 2004-03-03 | 刘晓雷 | Health-care liquid |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257879A (en) * | 2014-09-11 | 2015-01-07 | 成都中医药大学 | Novel use of Wuzi Yanzong prescription |
| CN104257879B (en) * | 2014-09-11 | 2018-08-03 | 成都中医药大学 | The new application of Wuzi Yanzong prescription |
| CN109528980A (en) * | 2019-01-18 | 2019-03-29 | 北京厚成医药科技有限公司 | A kind of Chinese medicine composition and its pharmacy application for treating Ovary reserve decline disease |
| CN109528980B (en) * | 2019-01-18 | 2021-09-17 | 北京厚成医药科技有限公司 | Traditional Chinese medicine composition for treating ovarian reserve function decline disease and pharmaceutical application thereof |
| CN113855771A (en) * | 2019-01-18 | 2021-12-31 | 北京厚成医药科技有限公司 | A Chinese medicinal composition for treating ovarian reserve function decline disease |
| CN113855771B (en) * | 2019-01-18 | 2022-09-09 | 北京厚成医药科技有限公司 | A Chinese medicinal composition for treating ovarian reserve function decline disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102166279B (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772748B (en) | Traditional Chinese medicine preparation for treating liver-depression qi-stagnation type viral myocarditis and preparation method thereof | |
| CN101417064A (en) | Traditional Chinese medicine combination for treating gynecology blood disease and preparation method thereof | |
| CN102120020B (en) | Medicinal composition for treating hyperplastic diseases of breast and hysteromyoma and preparation method thereof | |
| CN104208540B (en) | Compound traditional Chinese medicine for treating gastric cancer and preparation method thereof | |
| CN103735775A (en) | Traditional Chinese medicine composition for treating iron deficiency anemia | |
| CN101721658A (en) | Chinese herbal medicine pill for treating barrenness and gynecologic miscellaneous diseases | |
| CN102166279B (en) | Chinese medicinal composition for improving ovarian response and application thereof | |
| CN102085269B (en) | Traditional Chinese medicine composition for treating polycystic ovary syndrome (PCOS) and application thereof | |
| CN101209279B (en) | Chinese medicinal composition for ovulation induction in polycystic ovary syndrome and application | |
| CN104547418A (en) | Traditional Chinese medicine composition for treating hypoovarianism and application | |
| CN102343019B (en) | Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof | |
| CN102058718B (en) | Chinese medicinal composition for improving endometrial receptivity and application | |
| CN103263616B (en) | Traditional Chinese medicine composition for treating ectopic pregnancy and application | |
| CN101209313B (en) | Chinese medicinal composition and application | |
| CN103520354B (en) | Traditional Chinese medicine for treatment of blood-insufficiency type mammary gland hyperplasia and preparation method thereof | |
| CN102755491B (en) | Chinese medicinal composition for treating threatened abortion | |
| CN110237161A (en) | Drug and its preparation method and application for treating menopausal syndrome | |
| CN100475253C (en) | Medicine for treating barrenness, irregular menses, painful menstruation, endocrine dyscrasia and osteoporosis | |
| CN102755518A (en) | Medicinal prescription for treating recurrent abortion | |
| CN103877409B (en) | One treats hypothyroid Chinese medicine composition and application | |
| CN103877436B (en) | Traditional Chinese medicine composition for preventing hyperstimulation syndrome and application thereof | |
| CN103877186B (en) | A kind of Chinese medicine composition and application alleviating anxiety | |
| CN105395768A (en) | Pharmaceutical composition for treating qi-blood deficiency type hypomenorrhea | |
| CN102085352B (en) | Traditional Chinese medicine composition for preventing and controlling intrauterine residues after medicinal abortion and application thereof | |
| CN106943506A (en) | It is a kind of to treat pharmaceutical composition of menopausal syndrome and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 Termination date: 20130419 |